Literature DB >> 21659348

NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage.

Christiane Messaed1, Wafaa Chebaro, Raphael B Di Roberto, Cecile Rittore, Annie Cheung, Jocelyne Arseneau, Ariel Schneider, Moy Fong Chen, Kurt Bernishke, Urvashi Surti, Lori Hoffner, Philippe Sauthier, William Buckett, JianHua Qian, Nga Man Lau, Rashmi Bagga, James C Engert, Philippe Coullin, Isabelle Touitou, Rima Slim.   

Abstract

BACKGROUND: NLRP7 mutations are responsible for recurrent molar pregnancies and associated reproductive wastage. To investigate the role of NLRP7 in sporadic moles and other forms of reproductive wastage, the authors sequenced this gene in a cohort of 135 patients with at least one hydatidiform mole or three spontaneous abortions; 115 of these were new patients. METHODS/
RESULTS: All mutations were reviewed and their number, nature and locations correlated with the reproductive outcomes of the patients and histopathology of their products of conception. The presence of NLRP7 mutations was demonstrated in two patients with recurrent spontaneous abortions, and some rare non-synonymous variants (NSVs), present in the general population, were found to be associated with recurrent reproductive wastage. These rare NSVs were shown to be associated with lower secretion of interleukin 1β and tumour necrosis factor and therefore to have functional consequences similar to those seen in cells from patients with NLRP7 mutations. The authors also attempted to elucidate the cause of stillbirths observed in 13% of the patients with NLRP7 mutations by examining available placentas of the stillborn babies and live births from patients with mutations or rare NSVs. A number of severe to mild placental abnormalities were found, all of which are known risk factors for perinatal morbidity.
CONCLUSIONS: The authors recommend close follow-up of patients with NLRP7 mutations and rare NSVs to prevent the death of the rare or reduced number of babies that reach term.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659348     DOI: 10.1136/jmg.2011.089144

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages.

Authors:  Sonal Khare; Andrea Dorfleutner; Nicole B Bryan; Chawon Yun; Alexander D Radian; Lucia de Almeida; Yon Rojanasakul; Christian Stehlik
Journal:  Immunity       Date:  2012-02-21       Impact factor: 31.745

2.  Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Ange Lucien Diatta; Tarik Yadaden; Mamadou-Lamine Cissé; Jean-Marie Afoutou; Jean-Yves Picard; Benoît Mennesson; Rima Slim; Karim Si-Tayeb; Philippe Coullin
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

3.  NLRP7 inter-domain interactions: the NACHT-associated domain is the physical mediator for oligomeric assembly.

Authors:  Heike Singer; Arijit Biswas; Nicole Zimmer; Christiane Messaed; Johannes Oldenburg; Rima Slim; Osman El-Maarri
Journal:  Mol Hum Reprod       Date:  2014-07-31       Impact factor: 4.025

4.  ATP binding by NLRP7 is required for inflammasome activation in response to bacterial lipopeptides.

Authors:  Alexander D Radian; Sonal Khare; Lan H Chu; Andrea Dorfleutner; Christian Stehlik
Journal:  Mol Immunol       Date:  2015-07-02       Impact factor: 4.407

5.  Report of four new patients with protein-truncating mutations in C6orf221/KHDC3L and colocalization with NLRP7.

Authors:  Ramesh Reddy; Elie Akoury; Ngoc Minh Phuong Nguyen; Omar A Abdul-Rahman; Christine Dery; Neerja Gupta; William P Daley; Asangla Ao; Hanene Landolsi; Rosemary Ann Fisher; Isabelle Touitou; Rima Slim
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

6.  No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.

Authors:  L Aghajanova; S Mahadevan; S Altmäe; A Stavreus-Evers; L Regan; N Sebire; P Dixon; R A Fisher; I B Van den Veyver
Journal:  Hum Reprod       Date:  2014-11-05       Impact factor: 6.918

7.  Maternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring.

Authors:  Lukas Soellner; Matthias Begemann; Franziska Degenhardt; Annegret Geipel; Thomas Eggermann; Elisabeth Mangold
Journal:  Eur J Hum Genet       Date:  2017-05-31       Impact factor: 4.246

8.  The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.

Authors:  Ramesh Reddy; Ngoc M P Nguyen; Guillaume Sarrabay; Maryam Rezaei; Mayra C G Rivas; Aysenur Kavasoglu; Hakan Berkil; Alaa Elshafey; Ebtesam Abdalla; Kristin P Nunez; Hélène Dreyfus; Merviel Philippe; Zahra Hadipour; Asude Durmaz; Erin E Eaton; Brittany Schubert; Volkan Ulker; Fatemeh Hadipour; Fatemeh Ahmadpour; Isabelle Touitou; Majid Fardaei; Rima Slim
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

9.  No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform moles.

Authors:  Sangeetha Mahadevan; Shu Wen; Alfred Balasa; Gary Fruhman; Julio Mateus; Andrew Wagner; Tarek Al-Hussaini; Ignatia B Van den Veyver
Journal:  Prenat Diagn       Date:  2013-10-04       Impact factor: 3.050

10.  Abnormal processing of IL-1β in NLRP7-mutated monocytes in hydatidiform mole patients.

Authors:  P Zhang; X Zhu; X Yu; B Huang; T Jiang; X Zhang; H Yang; J Qian
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.